• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GSK ’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa

    GSK ’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa

  2. GlaxoSmithKline's Malaria Vaccine Clears Final Scientific Hurdle

    GlaxoSmithKline's Malaria Vaccine Clears Final Scientific Hurdle

  3. Research and Markets: H5N1 Infection (Avian Influenza) Pipeline Review 2015 - 42 Companies & 59 Drug Profiles

    Research and Markets: H5N1 Infection (Avian Influenza) Pipeline Review 2015 - 42 Companies & 59 Drug Profiles

  4. United Therapeutics Corporation Reports Second Quarter 2015 Financial Results

    United Therapeutics Corporation Reports Second Quarter 2015 Financial Results

  5. UPDATE: China just gave the Fed another headache

    UPDATE: China just gave the Fed another headache

  6. China just gave the Fed another headache

    China just gave the Fed another headache

  7. UPDATE: China just gave the Fed another headache

    UPDATE: China just gave the Fed another headache

  8. UPDATE: China just gave the Fed another headache

    UPDATE: China just gave the Fed another headache

  9. Research and Markets: Endometrial Cancer Therapeutics Pipeline Review, H1 2015 - 35 Companies & 48 Drug Profiles

    Research and Markets: Endometrial Cancer Therapeutics Pipeline Review, H1 2015 - 35 Companies & 48 Drug Profiles

  10. Novartis Pressured by Dollar Strength

    Novartis Pressured by Dollar Strength

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.